Baxter International Company Profile (NYSE:BAX)

About Baxter International

Baxter International logoBaxter International Inc., through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. The business also provides products and services related to pharmacy compounding, and drug formulation. The Renal business provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BAX
  • CUSIP: 07181310
Key Metrics:
  • Previous Close: $46.82
  • 50 Day Moving Average: $47.38
  • 200 Day Moving Average: $45.98
  • 52-Week Range: $34.06 - $50.16
  • Trailing P/E Ratio: 5.29
  • Foreward P/E Ratio: 22.48
  • P/E Growth: 1.88
  • Market Cap: $25.68B
  • Outstanding Shares: 543,887,000
  • Beta: 0.71
  • Net Margins: 48.68%
  • Return on Equity: 11.39%
  • Return on Assets: 5.54%
  • Debt-to-Equity Ratio: 0.25%
  • Current Ratio: 1.83%
  • Quick Ratio: 1.41%
Additional Links:
Companies Related to Baxter International:

Analyst Ratings

Consensus Ratings for Baxter International (NYSE:BAX) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $49.09 (4.01% upside)

Analysts' Ratings History for Baxter International (NYSE:BAX)
DateFirmActionRatingPrice TargetDetails
10/26/2016RBC Capital MarketsReiterated RatingSector Perform$50.00 -> $55.00View Rating Details
10/26/2016Evercore ISIReiterated RatingBuy$52.00 -> $56.00View Rating Details
10/26/2016Royal Bank Of CanadaBoost Price TargetSector Perform$50.00 -> $55.00View Rating Details
10/13/2016Wells Fargo & Co.Initiated CoverageOutperformView Rating Details
9/15/2016Barclays PLCInitiated CoverageOverweight$52.00View Rating Details
8/15/2016ArgusReiterated RatingHoldView Rating Details
7/27/2016JPMorgan Chase & Co.Boost Price TargetNeutral$45.00 -> $48.00View Rating Details
7/6/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
6/13/2016Piper Jaffray Cos.Reiterated RatingOverweight$60.00View Rating Details
5/17/2016Leerink SwannUpgradeMarket Perform -> OutperformView Rating Details
5/10/2016Credit Suisse Group AGReiterated RatingHoldView Rating Details
5/10/2016BMO Capital MarketsReiterated RatingHold$43.00View Rating Details
5/8/2016Morgan StanleyReiterated RatingSellView Rating Details
10/28/2015Cowen and CompanyLower Price Target$74.00 -> $38.00View Rating Details
7/31/2015S&P Equity ResearchDowngradeHold$42.00View Rating Details
7/13/2015Deutsche Bank AGReiterated RatingHold$66.00 -> $37.00View Rating Details
7/2/2015Bank of America Corp.DowngradeBuy -> NeutralView Rating Details
(Data available from 10/28/2014 forward)


Earnings History for Baxter International (NYSE:BAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016Q316$0.45$0.56$2.67 billion$2.56 billionViewListenView Earnings Details
7/26/2016Q216$0.40$0.46$2.51 billion$2.60 billionViewListenView Earnings Details
4/26/2016Q116$0.29$0.36$2.35 billion$2.40 billionViewListenView Earnings Details
2/2/2016Q415$0.32$0.43$2.55 billion$2.60 billionViewListenView Earnings Details
10/27/2015Q315$0.29$0.41$2.46 billion$2.49 billionViewListenView Earnings Details
7/29/2015Q215$0.94$1.00$2.40 billion$3.90 billionViewListenView Earnings Details
4/23/2015Q115$0.88$1.00$3.70 billion$3.76 billionViewListenView Earnings Details
1/29/2015Q414$1.32$1.34$4.37 billion$4.47 billionViewListenView Earnings Details
10/16/2014Q314$1.30$1.31$4.21 billion$4.20 billionViewListenView Earnings Details
7/17/2014Q214$1.22$1.26$4.12 billion$4.30 billionViewListenView Earnings Details
4/17/2014Q114$1.09$1.19$3.88 billion$3.95 billionViewListenView Earnings Details
1/23/2014Q413$1.25$1.26$4.25 billion$4.40 billionViewListenView Earnings Details
10/17/2013Q313$1.19$1.19$3.82 billion$3.80 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.13$1.16$3.70 billion$3.67 billionViewListenView Earnings Details
4/18/2013Q1 2013$1.04$1.05$3.49 billion$3.45 billionViewListenView Earnings Details
1/24/2013Q4 2012$1.26$1.26$3.72 billion$3.75 billionViewListenView Earnings Details
10/18/2012$1.14$1.14ViewN/AView Earnings Details
7/19/2012$1.11$1.12ViewN/AView Earnings Details
4/19/2012$1.00$1.01ViewN/AView Earnings Details
1/26/2012$1.17$1.17ViewN/AView Earnings Details
10/20/2011$1.08$1.09ViewN/AView Earnings Details
7/21/2011$1.02$1.07ViewN/AView Earnings Details
4/21/2011$0.93$0.98ViewN/AView Earnings Details
1/27/2011$1.10$1.11ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Baxter International (NYSE:BAX)
Current Year EPS Consensus Estimate: $1.88 EPS
Next Year EPS Consensus Estimate: $2.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.28$0.29$0.29
Q2 20163$0.36$0.39$0.38
Q3 20162$0.44$0.44$0.44
Q4 20162$0.51$0.51$0.51
Q1 20172$0.44$0.48$0.46
Q2 20172$0.51$0.51$0.51
Q3 20172$0.52$0.62$0.57
Q4 20172$0.54$0.59$0.57
Q1 20181$0.50$0.50$0.50
Q2 20181$0.57$0.57$0.57
(Data provided by Zacks Investment Research)


Current Dividend Information for Baxter International (NYSE:BAX)
Annual Dividend:$0.52
Dividend Yield:1.10%
Dividend Growth:4.80% (3 Year Average)
Payout Ratio:5.83% (Based on Trailing 12 Months of Earnings)
27.66% (Based on Current Year Consensus EPS Estimate)
24.76% (Based on Next Year Consensus EPS Estimate)

Dividend History for Baxter International (NYSE:BAX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Baxter International (NYSE:BAX)
Insider Ownership Percentage: 1.08%
Institutional Ownership Percentage: 84.38%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2016Jose E AlmeidaCEOBuy11,691$42.75$499,790.25View SEC Filing  
5/2/2016John D ForsythDirectorSell1,887$44.38$83,745.06View SEC Filing  
4/4/2016John D ForsythDirectorSell1,887$41.75$78,782.25View SEC Filing  
3/14/2016James R Gavin IIIDirectorSell5,660$40.34$228,324.40View SEC Filing  
2/17/2016Peter S. HellmanDirectorSell5,660$38.35$217,061.00View SEC Filing  
2/11/2016Kornelis J. StormDirectorSell5,660$35.98$203,646.80View SEC Filing  
5/22/2015Carole J ShapazianDirectorSell1,533$67.68$103,753.44View SEC Filing  
4/27/2015James R Gavin IIIDirectorSell4,830$71.06$343,219.80View SEC Filing  
7/25/2014Carole J ShapazianDirectorSell1,645$76.98$126,632.10View SEC Filing  
7/24/2014Thomas T StallkampDirectorSell8,300$76.82$637,606.00View SEC Filing  
7/9/2014Ludwig HantsonVPSell24,693$76.00$1,876,668.00View SEC Filing  
5/2/2014Carole ShapazianDirectorSell5,680$75.28$427,590.40View SEC Filing  
4/23/2014Kees StormDirectorSell5,760$72.45$417,312.00View SEC Filing  
4/21/2014Blake DevittDirectorSell4,334$73.12$316,902.08View SEC Filing  
3/27/2014Sebastian BufalinoVPSell21,600$75.10$1,622,160.00View SEC Filing  
9/12/2013Carole ShapazianDirectorSell1,941$71.58$138,936.78View SEC Filing  
8/1/2013Robert L Parkinson JrCEOSell725,750$73.33$53,219,247.50View SEC Filing  
7/26/2013David P ScharfVPSell55,438$73.79$4,090,770.02View SEC Filing  
7/25/2013James R Gavin IIIDirectorSell5,760$72.82$419,443.20View SEC Filing  
7/24/2013Carole J ShapazianDirectorSell4,320$73.58$317,865.60View SEC Filing  
7/22/2013Robert J HombachCFOSell47,452$73.95$3,509,075.40View SEC Filing  
7/16/2013Phillip L BatchelorVPSell5,850$73.00$427,050.00View SEC Filing  
5/22/2013Blake E DevittDirectorSell1,000$72.34$72,340.00View SEC Filing  
5/20/2013Sebastian J BufalinoVPSell24,000$73.75$1,770,000.00View SEC Filing  
5/17/2013Robert M DavisVPSell130,800$73.00$9,548,400.00View SEC Filing  
9/13/2012Michael J BaughmanVPSell11,500$61.00$701,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Baxter International (NYSE:BAX)
DateHeadline logoBaxter International, Inc. breached its 50 day moving average in a Bearish Manner : BAX-US : October 28, 2016 (NYSE:BAX) - October 28 at 12:31 PM logoBaxter International : Recently Launched SHARESOURCE Telehealth System Has Securely Managed 150,000 Home Dialysis Patient Treatments Globally (NYSE:BAX) - October 27 at 9:20 PM
News IconLeading stocks in today’s market: Baxter International Inc. (NYSE:BAX) (NYSE:BAX) - October 27 at 9:20 PM logoBaxter International, Inc. :BAX-US: Earnings Analysis: Q3, 2016 By the Numbers : October 27, 2016 (NYSE:BAX) - October 27 at 4:02 PM
News IconWorth Watching Stocks on the Move: Baxter International Inc (NYSE:BAX), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - NYSE Journal (press release) (NYSE:BAX) - October 27 at 8:13 AM logoBaxter International Inc 11.9% Potential Upside Now Implied by ... - DirectorsTalk Interviews (NYSE:BAX) - October 27 at 8:13 AM
News IconBaxter International Inc Gets More Efficient - Fox Business (NYSE:BAX) - October 27 at 8:13 AM logoBaxter’s AMIA with SHARESOURCE Telehealth Platform for Home Dialysis Named a Winner of 15th Annual Chicago Innovation Awards (NYSE:BAX) - October 27 at 8:13 AM logoBaxter Rolls Out New Kidney Filter Therapy (BAX) (NYSE:BAX) - October 27 at 8:13 AM logoBaxter International Inc Gets More Efficient (NYSE:BAX) - October 26 at 4:13 PM logoBaxter International Inc Gets More Efficient - Motley Fool (NYSE:BAX) - October 26 at 3:48 PM
News IconScorching Stocks in Action- Bristol-Myers Squibb Firm (NYSE:BMY), Baxter International Inc. (NYSE:BAX) - Seneca Globe (NYSE:BAX) - October 26 at 12:42 PM logoBRIEF-Baxter Q3 adj earnings per share $0.56 from continuing operations excluding items (NYSE:BAX) - October 25 at 8:53 PM logoBaxter International Inc. Q3 Earnings Rise 38% (NYSE:BAX) - October 25 at 8:53 PM
News IconTop Gainers of the Day: Baxter International Inc. (NYSE:BAX) from Medical Instruments & Supplies (NYSE:BAX) - October 25 at 8:53 PM logoBaxter International (BAX) Q3 2016 Results - Earnings Call Transcript (NYSE:BAX) - October 25 at 8:52 PM logoEdited Transcript of BAX earnings conference call or presentation 25-Oct-16 12:30pm GMT (NYSE:BAX) - October 25 at 8:52 PM
News IconNewsmaking Penny Stock: Investors Checking Out Baxter International Inc. (NYSE:BAX) - Duncan Research (NYSE:BAX) - October 25 at 3:45 PM
News IconMovers to Watch For: Kimberly-Clark Corporation (NYSE:KMB), Baxter International Inc. (NYSE:BAX) - The Newburgh Press (NYSE:BAX) - October 25 at 8:37 AM
News IconBaxter International Inc. (NYSE:BAX) Analysts Recommendations ... - The Independent Republic (NYSE:BAX) - October 25 at 8:37 AM
News IconGilead Sciences, Inc. (NASDAQ:GILD) & Baxter International Inc (NYSE:BAX) Stocks in the Spotlight - Money News (NYSE:BAX) - October 25 at 8:37 AM
News IconEarnings To Observe: Baxter International Inc (BAX)'s EPS3 have been projected to Decrease, according to analysts - MoneyMakingArticles (NYSE:BAX) - October 25 at 8:37 AM logoBaxter tops Street 3Q forecasts (NYSE:BAX) - October 25 at 8:37 AM logoBaxter International Inc Earnings Call scheduled for 8:30 am ET today (NYSE:BAX) - October 25 at 8:37 AM logoBaxter Launches HDx Therapy Enabled by THERANOVA to Provide ... - Business Wire (press release) (NYSE:BAX) - October 24 at 3:46 PM
News IconStocks under Consideration: Microsemi Corporation (NASDAQ ... - The Newburgh Press (NYSE:BAX) - October 24 at 3:46 PM
News IconResearch Reports on Healthcare Equities -- Valeant Pharma, Skyline Medical, Baxter, and DENTSPLY (NYSE:BAX) - October 24 at 8:37 AM logoMedical Product Oct 25 Earnings Roster: BAX, RMD, CPHD, EW (NYSE:BAX) - October 24 at 8:37 AM logoBaxter International : Research Reports on Healthcare Equities -- Valeant Pharma, Skyline Medical, Baxter, and DENTSPLY (NYSE:BAX) - October 24 at 8:37 AM logoWhat's in Store for GNC Holdings (GNC) in Q3 Earnings? (NYSE:BAX) - October 24 at 8:37 AM logoWhat Do Analysts Recommend for Baxter Ahead of Its 3Q16 Results? (NYSE:BAX) - October 24 at 8:37 AM logoBaxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments (NYSE:BAX) - October 24 at 8:37 AM
News IconKlingenstein Fields & Co. LLC Reached $2522000 position of Baxter International Inc. (BAX) - DailyQuint (NYSE:BAX) - October 23 at 8:29 AM logoBaxter International (BAX) Q3 Earnings: Beat in the Cards? - Nasdaq (NYSE:BAX) - October 22 at 3:41 PM
News IconIt's Earnings Time: What to Do with Baxter International Inc. (NYSE:BAX) Stock - The Voice Registrar (NYSE:BAX) - October 22 at 3:41 PM logoBaxter International Inc. (NYSE:BAX) Is Expected To Post EPS Of $0.51 (NYSE:BAX) - October 22 at 5:00 AM logoBaxter International Inc. (NYSE:BAX) Is Expected To Post EPS Of $0.51 - (NYSE:BAX) - October 21 at 8:45 PM
News IconBaxter International Inc. (NYSE:BAX) from Medical Instruments & Supplies – Todays Top Gains (NYSE:BAX) - October 21 at 3:45 PM logoBaxter International : EUROLIFE BUYS BAXTER INDIA'S FFS INFUSIONS BUSINESS (NYSE:BAX) - October 21 at 10:14 AM logoBaxter International (BAX) Q3 Earnings: Beat in the Cards? (NYSE:BAX) - October 21 at 10:14 AM logoShould You Sell Baxter International (BAX) Before Earnings? (NYSE:BAX) - October 21 at 10:14 AM logoBAXTER INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers (NYSE:BAX) - October 20 at 9:43 PM logoBaxter International : Vaughan David Investments INC Lowered Its Baxter International INC Stake by $10.34 Million as Stock Price Rose (NYSE:BAX) - October 20 at 4:11 PM
News IconMedical Instruments & Supplies: Baxter International Inc. (NYSE:BAX) Position of the day (NYSE:BAX) - October 20 at 4:11 PM logoInvestor's Watch List HollyFrontier Corp (NYSE:HFC), Baxter International Inc (NYSE:BAX) - Wall Street 24 (NYSE:BAX) - October 20 at 9:37 AM
News IconAnalysts Valuations For Two Stocks: Baxter International Inc. (NYSE:BAX), Equity Residential (NYSE:EQR) - The Voice Registrar (NYSE:BAX) - October 20 at 9:37 AM
News IconSell-side is Weighing in on Baxter International Inc. (NYSE:BAX) Earnings - CSZ News (NYSE:BAX) - October 19 at 4:34 PM
News IconEarnings Reaction History: Baxter International Inc. (NYSE:BAX) has a 59.26% chance to rise - The Independent Republic (NYSE:BAX) - October 19 at 4:34 PM logoBaxter’s Recently Launched SHARESOURCE Telehealth System Has Securely Managed 150,000 Home Dialysis Patient Treatments Globally (NYSE:BAX) - October 19 at 4:34 PM logoETF’s with exposure to Baxter International, Inc. : October 19, 2016 (NYSE:BAX) - October 19 at 4:34 PM


Baxter International (NYSE:BAX) Chart for Friday, October, 28, 2016

Last Updated on 10/28/2016 by Staff